SCHEMBL24891024

SCHEMBL24891024

CC1CCN(C(=O)CCOCCN)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.59
ALDH1A1 P00352 8/20 0.50
HPGD P15428 7/20 0.47
KMT2A Q03164 4/20 0.47
LMNA P02545 3/20 0.47
MEN1 O00255 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
RAB9A P51151 1/20 0.46
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
GNAI3 P08754 1/20 0.39
GNAO1 P09471 1/20 0.39
GNAI1 P63096 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24890775 0.98 NPC1 (0.57) NPC1ALDH1A1HPGDKMT2ALMNA
SCHEMBL24891020 0.86 NPC1 (0.57) NPC1ALDH1A1HPGDKMT2ALMNA
SCHEMBL21946675 0.84 GNAI3 (0.40) NPC1ALDH1A1RAB9AGNAI3GNAO1
SCHEMBL27456239 0.84 NPC1 (0.59) NPC1ALDH1A1HPGDKMT2ALMNA
SCHEMBL21946396 0.84 NPC1 (0.39) NPC1ALDH1A1HPGDKMT2ALMNA
SCHEMBL14274126 0.84 NPC1 (0.59) NPC1ALDH1A1HPGDKMT2ALMNA
SCHEMBL14294014 0.84 NPC1 (0.59) NPC1ALDH1A1HPGDKMT2ALMNA
SCHEMBL12410266 0.83 NPC1 (0.62) NPC1ALDH1A1HPGDKMT2ALMNA
SCHEMBL23484938 0.83 NPC1 (0.39) NPC1ALDH1A1HPGDKMT2ALMNA
SCHEMBL15224251 0.83 NPC1 (0.71) NPC1ALDH1A1HPGDKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023004163-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH ENHANCED IMID ACTIVITY NURIX THERAPEUTICS, INC. (US) 2023-01-26 WO disclosed
WO-2023287928-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH DIMINISHED IMID ACTIVITY NURIX THERAPEUTICS, INC. (US) 2023-01-19 WO disclosed